Omega-3
PRECLINICAL
PHASE 1
PHASE 2
PHASE 3
PRE
P1
P2
P3
Edit
Updated: 05/17/2019
Pipeline Type
Dietary Supplements
Phase Of Development
Phase 2
Sponsors and Collaborators
Seoul National University Hospital
Mechanism of Action
Mechanism Description
N/A
Populations Tested In
To determine whether omega-3 is effective in RX of refractory epilepsy as adjunctive therapy
Other Resources
Special FDA Designation
Nonprofit or Government Support
N/A
Nonprofit or Government Support Description
N/A
Previous Presentations
Presented at meetings (latest date) (Pipeline, AEDD; AES, Eilat, etc)
N/A
Location of Clinical Trials
Seoul National University Hospital
Korea
Clinical Trial link